CTT Pharmaceutical Holdings, Inc. (CTTH) Research

CTT Pharmaceutical Holdings, Inc. is dedicated to developing innovative oral drug delivery systems, particularly those aimed at pain management and treatment. The company's core expertise lies in rapidly dissolving dosage forms. Central to their technological portfolio are advanced, thin oral wafers designed to be impregnated with natural or synthetic cannabis extracts, presenting an alternative to traditional consumption methods such as smoking or ingestion. Their key proprietary asset is a patented, orally administered wafer, formulated with at least one physiologically acceptable film-forming agent. The entity, formerly known as Mindesta Inc., officially rebranded as CTT Pharmaceutical Holdings, Inc. in July 2015. Its operations are based in Ottawa, Canada.

Market snapshot

Symbol
CTTH
Price
$0.08
Day change
0.00%
Market cap
$1.7M
P/E ratio
-29.79x
52-week range
0.02-0.1
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Bionoid Pharma, Inc. (BINP)
  • BioTech Medics, Inc. (BMCS)
  • Body and Mind Inc. (BMMJ)
  • Endexx Corporation (EDXC)
  • Galexxy Holdings, Inc. (GXXY)
  • Herborium Group, Inc. (HBRM)
  • Medical Marijuana, Inc. (MJNA)
  • Ovation Science Inc. (OVATF)

Recent insider activity

  • CTT PHARMACEUTICAL HOLDINGS, INC. — P-Purchase (8300 shares) on 2025-12-17
  • CTT PHARMACEUTICAL HOLDINGS, INC. — P-Purchase (200000 shares) on 2025-11-20
  • CTT PHARMACEUTICAL HOLDINGS, INC. — P-Purchase (62900 shares) on 2025-11-20
  • CTT PHARMACEUTICAL HOLDINGS, INC. — P-Purchase (7000 shares) on 2025-10-31
  • CTT PHARMACEUTICAL HOLDINGS, INC. — P-Purchase (6815 shares) on 2025-09-23

Open CTT Pharmaceutical Holdings, Inc. (CTTH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.